Nasdaq Erna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq erna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Erna Today - Breaking & Trending Today

Short Interest in Eterna Therapeutics Inc. (NASDAQ:ERNA) Rises By 261.2%

Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 134,000 shares, an increase of 261.2% from the December 15th total of 37,100 shares. Based on an average daily trading volume, of 34,300 […] ....

Eterna Therapeutics Inc , Eterna Therapeutics Company Profile , Vanguard Group Inc , Goldman Sachs Group Inc , Geode Capital Management , Renaissance Technologies , Eterna Therapeutics , Get Free Report , Sachs Group , Capital Management , Capital Advisors , Vanguard Group , Therapeutics Trading Down , Therapeutics Inc , Eterna Therapeutics Daily , Nasdaq Erna ,

Short Interest in Eterna Therapeutics Inc. (NASDAQ:ERNA) Drops By 7.0%

Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) saw a large decrease in short interest in November. As of November 30th, there was short interest totalling 114,700 shares, a decrease of 7.0% from the November 15th total of 123,300 shares. Based on an average daily volume of 26,700 shares, the short-interest ratio is presently 4.3 […] ....

Eterna Therapeutics Inc , Ci Private Wealth , Renaissance Technologies , Goldman Sachs Group Inc , Eterna Therapeutics Company Profile , Geode Capital Management , Eterna Therapeutics , Get Free Report , Capital Advisors , Sachs Group , Therapeutics Stock Down , Therapeutics Inc , Eterna Therapeutics Daily , Nasdaq Erna ,

Eterna Therapeutics Inc. (NASDAQ:ERNA) Short Interest Update

Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the target of a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 97,900 shares, a decline of 6.6% from the July 31st total of 104,800 shares. Approximately 3.2% of the company’s shares are sold short. […] ....

Renaissance Technologies , Geode Capital Management , Eterna Therapeutics Inc , Ci Private Wealth , Goldman Sachs Group Inc , Eterna Therapeutics , Get Free Report , Sachs Group , Capital Management , Capital Advisors , Therapeutics Inc , Eterna Therapeutics Daily , Nasdaq Erna ,